Unraveling the Genetics of Osteosarcoma
New findings shed light on the genes behind osteosarcoma and its spread.
― 5 min read
Table of Contents
Osteosarcoma, or OSA for short, is the most common type of bone cancer that mostly affects kids and teens. Imagine a big club where every year, about 4.4 kids out of every million get their invitation to the "osteosarcoma" party. Unfortunately, not everyone gets a happy ending at this party, as around 15-20% of these kids find out their cancer has spread to other parts of their body, usually the lungs.
Treatment Options
When it comes to treating OSA, doctors often choose surgery to remove the main tumor, along with some tough medications like methotrexate, doxorubicin, and cisplatin. The good news is that thanks to better ways to diagnose and treat this cancer, the chance of surviving for five years has jumped from less than 20% to between 65-70%. However, for those who have cancer spread elsewhere, the long-term survival rate is still pretty low, around 20-30%. So, researchers are on a mission to find out more about what drives this disease.
What are Scientists Doing?
Researchers are diving into the Genes of osteosarcoma to figure out which ones are responsible for causing the cancer to spread. They looked at data from eight different sets of OSA patients, comparing the gene activity in tumors versus healthy bone, primary tumors versus Metastatic ones, and so on. They used various tools to understand how these genes work together, sort of like putting together a puzzle where some pieces may end up missing.
Data Gathering
To carry out their research, scientists grabbed information from various sources. One big dataset called TARGET-OS contained information about 87 patients, where 32 had spread (metastatic) disease and 55 did not. Among these patients, there were 50 boys and 37 girls, and they had an average age of 14. Other datasets came from a website that collects genetic data, and the scientists used a special tool to find out which genes were more active in different groups of patients.
Finding the Differences in Gene Activity
Using a method called DESeq2, scientists compared the gene activity in metastatic versus non-metastatic patients. They found a total of 223 genes that were switching things up, with 99 showing higher activity in patients with metastasis and 124 showing lower activity. They created visual aids, kind of like colorful infographics, to highlight the important genes involved.
What Do the Genes Do?
These scientists didn’t stop at just finding which genes were active. They went deeper into what these genes do. For this, they used tools that check for "enrichment," which is a fancy way to see if certain genes are more likely to be involved in specific processes. They found that many active genes were related to Muscle Functions, cell growth, and Cell Communication. Specifically, genes that help with muscle contraction and various signaling pathways like BMP, Wnt, and p53 were notable players.
Comparing to Other Data
To see how the findings held up elsewhere, the research team also investigated three other datasets. They found some genes that were similarly less active in different studies. Several important functions, like how cells communicate and regulate themselves, popped up as common themes across these datasets.
What Happens in Metastasis?
Next, the researchers looked at what happens when OSA spreads from the bone to other parts of the body. They found that certain genes were showing off their activity in multiple datasets. The top genes were linked to how cells stick together and communicate, which is often disrupted when cancer spreads.
What Do All These Findings Mean?
The overall findings have painted a clearer picture of osteosarcoma. For example, genes responsible for muscle movement and other vital processes were found to be quite active in patients with metastasis. These hints help paint a larger picture of how this disease operates.
What About Normal Bones?
To understand how OSA compares to normal bones, the researchers looked into three more datasets. They discovered several genes that were more active in osteosarcoma as compared to normal bones. They noticed some genes were important for functions like cell cycles and immune responses, which are crucial in how the body fights disease.
The Big Picture
So, what are we taking away from all this? The research suggests that when it comes to osteosarcoma, certain genes play leading roles in how this bone cancer behaves, especially when it decides to spread. It seems like a lot of factors come into play, from how well cells stick together to how they communicate, to how they respond to signals from the rest of the body.
Wrapping It Up
While it sounds a bit serious, studying cancer is like piecing together a giant jigsaw puzzle. Each piece of information adds to the understanding of how this disease works, aiming to improve treatments and outcomes for those affected. With ongoing efforts to uncover the roles of different genes, researchers hope to continue making progress in the fight against osteosarcoma. Let's give a round of applause for them; they sure are working hard to kick cancer to the curb!
Title: Analysis of publicly available transcriptomic data to identify key genes and pathways associated with osteosarcoma metastasis
Abstract: Osteosarcoma is the most common bone tumor occurring in children and adolescents. The prognosis of osteosarcoma patients with metastasis is rather poor, availability of prognostic molecular markers would thereby help to distinguish patients with a worse prognosis and to choose appropriate treatment. This study aimed to analyze data from publicly available datasets to identify genes and pathways associated with osteosarcoma onset and metastasis. A total of 8 datasets were analyzed (TARGET-OS, GSE220538, GSE21257, GSE9508, GSE87624, GSE14359, GSE19276, and GSE36001), and common deregulated genes and abundant pathways were searched. Three downregulated genes, TMBIM4, PKIB and IGKC, were common between metastatic and non-metastatic osteosarcoma tumors. Several abundant GO terms and pathways were identified, including Apoptotic Process (GO:0006915), Regulation Of Phosphatidylinositol 3-Kinase Signaling (GO:0014066), Regulation Of Cell Adhesion Molecule Production (GO:0060353), Positive Regulation Of MAP Kinase Activity (GO:0043406), and KEGG pathway Adherens junction. Analysis of metastasis versus primary tumor revealed 231 common deregulated genes, identified hub genes involved in the organization of cell-cell junctions and surfactant metabolism. Significant enrichment was found in tight junctions, actin cytoskeleton, focal adhesion, muscle contraction proteins, NF-{kappa}B, PIK3/Akt/mTOR, AMPK, TNF, and MAPK signaling. 335 common deregulated genes were found between tumor and normal bone, network analysis revealed two clusters involved in cell cycle progression and G2/M transition, and immune response regulation. Abundance was found in p53, TNF, MAPK, and JAK-STAT pathways. Taken together, this study consolidated transcriptomic data from 8 publicly available datasets to identify common deregulated genes and pathways in osteosarcoma development and metastasis.
Authors: Iryna Horak
Last Update: 2024-11-28 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.11.27.623785
Source PDF: https://www.biorxiv.org/content/10.1101/2024.11.27.623785.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.
Reference Links
- https://www.cancer.gov/ccg/research/genome-sequencing/target/studied-cancers/osteosarcoma
- https://xenabrowser.net/datapages/?dataset=TARGET-OS.star_counts.tsv&host=https%3A%2F%2Fgdc.xenahubs.net&removeHub=https%3A%2F%2Fxena.treehouse.gi.ucsc.edu%3A443
- https://bioinformatics.psb.ugent.be/webtools/Venn/
- https://string-db.org/